10-Q quarterly report · filed Nov 5, 2026

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) Q3 2026 10-Q Quarterly Report

Short answer

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $46M (up 10.1% year over year) with net income of −$14M.

Q3 2026 key financials · XBRL

Revenue
$46M
+10.1% YoY · −10.9% QoQ
Net income
−$14M
+45.8% YoY · −11.5% QoQ
Operating margin
-45.0%
Gross margin
35.3%
EPS (diluted)
−$0.09
+50.0% YoY · +0.0% QoQ

Source: XBRL data from the MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) Q3 2026 10-Q on SEC EDGAR. USD.

MARAVAI LIFESCIENCES HOLDINGS, INC. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $45.9M, up 10.1% YoY from $41.6M
  • Gross margin 35.3% vs 13.6% YoY, net loss $24.0M vs $45.1M
  • Best segment TriLink: $28.4M, up 11.8%; Cygnus $17.5M, up 7.5%
  • Operating cash flow $17.7M vs $(34.8)M YoY; cash $73.0M at September 30
  • No further high-volume CleanCap COVID orders expected in 2026; 2027 binding orders absent

Risk Factors

  • No material changes to previously disclosed risk factors since the December 31, 2025 Form 10-K

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other MARAVAI LIFESCIENCES HOLDINGS, INC. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.